UCAM researcher will study new advances against colorectal cancer in New York
She has won one of the 16 Fulbright grants awarded by the US to Spain to achieve new advances against this tumour, which has the second highest mortality rate in the world
Molecular medicine to individualise the treatment of metastatic cancer
UCAM has created Spain's first chair in this discipline, directed by Dr Fernando Vidal Vanaclocha, who describes the work he is carrying out in this interview.
UCAM publishes a 'Handbook on the assessment of occupational capacity/disability due to breast cancer'
Its International Chair in Evaluative and Expert Medicine has analysed the impact of this disease on working women, due to its high incidence and the fact that, despite the good prognosis in most cases, it causes sequelae and difficulties to return to work.
The research aimed at accelerating early diagnosis of cervical cancer is open to citizen collaboration
Through an economic contribution or by disseminating the project it is possible to collaborate to this research, included in the FECYT Precipita platform (Spanish Ministry of Science and Innovation), which aims at developing a screening system through artificial intelligence that would reduce by 85% the pathologist’s workload, thus allowing to implement a population programme of early diagnosis. It is developed by researchers of UCAM Universidad Católica San Antonio de Murcia, the Polytechnic University of Valencia, the CIAGO Gynaecological Clinic of Torre Pacheco and the Santa Lucía and Santa María del Rosell university hospitals of Cartagena.
The Royal Academy of Medicine gives an award to one UCAM student and three UCAM researchers
The recipients of the awards are Javier Bernal, for the best academic record of the Bachelor’s Degree in Medicine, Begoña Alburquerque, Carmen Lucas and Rebeca González, for their researches on the treatment of colorectal cancer and male baldness
An existing drug may block metastases in colorectal cancer
The development of this patent has been possible thanks to the study carried out by UCAM and the IMIB to find new drugs that act by reducing the migration and invasion of tumour cells
The patent for an anti-tumour drug is being developed in the Region of Murcia, with clinical trials to be carried out on a global scale
The researchers belong to the Universidad Católica de Murcia, the Murcian Institute of Biosanitary Research and the University of Granada.
Significant advances in the effectiveness of vitamin C to treat persistent cancers
UCAM and Fundación Jiménez Díaz develop a project led by Dr. Óscar Aguilera that provides important results regarding the use of Vitamin C in the treatment of tumours resistant to chemotherapy.